| Net income | 26.96M |
| Depreciation, depletion and amortization | 40.1M |
| Gain on distribution to non-controlling interest | |
| Deferred tax expense (benefit) | -1.03M |
| Non-cash employee stock compensation expense | 4.14M |
| Gain on royalty restructuring | |
| Tax benefit of stock-based compensation exercises | |
| Other | |
| Royalty receivables | -5.96M |
| Prepaid expenses and other assets | -1.72M |
| Accounts payable | 1.78M |
| Income taxes (receivable) payable | 6.37M |
| Other liabilities | 879K |
| Net cash provided by operating activities | |
| Acquisition of royalty interests in mineral properties | |
| Acquisition of International Royalty Corporation, net of cash acquired | |
| Acquisition of available for sale securities | |
| Change in restricted cash - compensating balance | |
| Proceeds on sale of inventory - restricted | |
| Deferred acquisition costs | |
| Other | -226K |
| Net cash used in investing activities | |
| Borrowings from credit facilities | |
| Tax benefit of stock-based compensation exercises | |
| Common stock dividends | -15.01M |
| Repayment of debt | |
| Proceeds from foreign exchange contract | |
| Distribution to non-controlling interests | |
| Net proceeds from issuance of common stock | |
| Debt issuance costs | |
| Other | -315K |
| Net cash (used in) provided by financing activities | |
| Net (decrease) increase in cash and equivalents | |
| Cash and equivalents at beginning of period | 116.63M |
| Cash and equivalents at end of period | 133.04M |